
Cion TZ 250mg/31.25mg Injection
Marketer
Biosys Medisciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cion TZ 250mg/31.25mg Injection
Cion TZ Injection (250mg/31.25mg) combines multiple medications to combat various bacterial infections. Its action inhibits microbial growth, curbing infection spread. Administration must be overseen by a medical professional; strict adherence to the prescribed schedule is crucial. Complete the full treatment course, even with symptom improvement, as premature cessation may compromise efficacy. Nausea, vomiting, diarrhea, and indigestion are potential side effects; worsening symptoms necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Disclose all current medications to your physician before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing to driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration promote faster recovery. Your doctor may order lab tests and diagnostics to monitor treatment response.
Uses of Cion TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cion TZ 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Cion TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cion TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Cion TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Cion TZ 250mg/31.25mg Injection, offer a targeted antibacterial approach. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Cion TZ 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Cion TZ 250mg/31.25mg Injection is typically deemed safe for pregnant individuals. Preclinical trials in animals have revealed minimal or no harmful consequences to the fetus; nevertheless, research involving human subjects is scant.
Breast feedingCAUTION
Administering Cion TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cion TZ 250mg/31.25mg Injection could induce drowsiness, blurred vision, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data on the application of Cion TZ 250mg/31.25mg Injection in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should receive Cion TZ 250mg/31.25mg Injection with close monitoring; dosage modification may be necessary. Medical advice is recommended. Dosage alteration for Cion TZ 250mg/31.25mg Injection is not advised for individuals with mild or moderate liver dysfunction.
What if you forget to take Cion TZ 250mg/31.25mg Injection :
Should you forget a scheduled injection of Cion TZ 250mg/31.25mg, seek medical advice.
Facts to Know About Cion TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
